417 related articles for article (PubMed ID: 27246997)
21. The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.
Hawkins NA; Lewis M; Hammond RS; Doherty JJ; Kearney JA
Sci Rep; 2017 Nov; 7(1):15327. PubMed ID: 29127345
[TBL] [Abstract][Full Text] [Related]
22. A selective Na
Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
[TBL] [Abstract][Full Text] [Related]
23. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome.
Weuring WJ; Singh S; Volkers L; Rook MB; van 't Slot RH; Bosma M; Inserra M; Vetter I; Verhoeven-Duif NM; Braun KPJ; Rivara M; Koeleman BPC
PLoS One; 2020; 15(3):e0219106. PubMed ID: 32134913
[TBL] [Abstract][Full Text] [Related]
24. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
[TBL] [Abstract][Full Text] [Related]
25. Selective Na
Richards KL; Milligan CJ; Richardson RJ; Jancovski N; Grunnet M; Jacobson LH; Undheim EAB; Mobli M; Chow CY; Herzig V; Csoti A; Panyi G; Reid CA; King GF; Petrou S
Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8077-E8085. PubMed ID: 30076230
[TBL] [Abstract][Full Text] [Related]
26. Dravet Syndrome: A Developmental and Epileptic Encephalopathy.
Lopez-Santiago L; Isom LL
Epilepsy Curr; 2019 Jan; 19(1):51-53. PubMed ID: 30838929
[TBL] [Abstract][Full Text] [Related]
27. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.
Mistry AM; Thompson CH; Miller AR; Vanoye CG; George AL; Kearney JA
Neurobiol Dis; 2014 May; 65():1-11. PubMed ID: 24434335
[TBL] [Abstract][Full Text] [Related]
28. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
29. Interneuron Desynchronization Precedes Seizures in a Mouse Model of Dravet Syndrome.
Tran CH; Vaiana M; Nakuci J; Somarowthu A; Goff KM; Goldstein N; Murthy P; Muldoon SF; Goldberg EM
J Neurosci; 2020 Mar; 40(13):2764-2775. PubMed ID: 32102923
[TBL] [Abstract][Full Text] [Related]
30. Clinical and genetic factors predicting Dravet syndrome in infants with
Cetica V; Chiari S; Mei D; Parrini E; Grisotto L; Marini C; Pucatti D; Ferrari A; Sicca F; Specchio N; Trivisano M; Battaglia D; Contaldo I; Zamponi N; Petrelli C; Granata T; Ragona F; Avanzini G; Guerrini R
Neurology; 2017 Mar; 88(11):1037-1044. PubMed ID: 28202706
[TBL] [Abstract][Full Text] [Related]
31. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
32. Distinct types of ionic modulation of GABA actions in pyramidal cells and interneurons during electrical induction of hippocampal seizure-like network activity.
Fujiwara-Tsukamoto Y; Isomura Y; Imanishi M; Fukai T; Takada M
Eur J Neurosci; 2007 May; 25(9):2713-25. PubMed ID: 17459104
[TBL] [Abstract][Full Text] [Related]
33. Postnatal changes in somatic gamma-aminobutyric acid signalling in the rat hippocampus.
Tyzio R; Minlebaev M; Rheims S; Ivanov A; Jorquera I; Holmes GL; Zilberter Y; Ben-Ari Y; Khazipov R
Eur J Neurosci; 2008 May; 27(10):2515-28. PubMed ID: 18547241
[TBL] [Abstract][Full Text] [Related]
34. The therapeutic effect of stiripentol in Gabrg2
Warner TA; Smith NK; Kang JQ
Epilepsy Res; 2019 Aug; 154():8-12. PubMed ID: 31022638
[TBL] [Abstract][Full Text] [Related]
35. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.
Tai C; Abe Y; Westenbroek RE; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3139-48. PubMed ID: 25024183
[TBL] [Abstract][Full Text] [Related]
36. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome.
Aras LM; Isla J; Mingorance-Le Meur A
Epilepsy Behav; 2015 Mar; 44():104-9. PubMed ID: 25666511
[TBL] [Abstract][Full Text] [Related]
37. Use-dependent shift from inhibitory to excitatory GABAA receptor action in SP-O interneurons in the rat hippocampal CA3 area.
Lamsa K; Taira T
J Neurophysiol; 2003 Sep; 90(3):1983-95. PubMed ID: 12750426
[TBL] [Abstract][Full Text] [Related]
38. Dravet syndrome and its mimics: Beyond SCN1A.
Steel D; Symonds JD; Zuberi SM; Brunklaus A
Epilepsia; 2017 Nov; 58(11):1807-1816. PubMed ID: 28880996
[TBL] [Abstract][Full Text] [Related]
39. GABAA-mediated IPSCs in piriform cortex have fast and slow components with different properties and locations on pyramidal cells.
Kapur A; Pearce RA; Lytton WW; Haberly LB
J Neurophysiol; 1997 Nov; 78(5):2531-45. PubMed ID: 9356403
[TBL] [Abstract][Full Text] [Related]
40. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
Liebergall SR; Goldberg EM
J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
